Hazte socio de la SAMFyC

Última publicación SAMFyC: Actualización en MF y APS

 

AULA VIRTUAL SAMFyC

Aula de formación virtual de SAMFyC

SAMFyC CONGRESOS

Historico de Comunicaciones
presentadas a los Congresos
Andaluces de MFyC (SAMFyC), desde 2008.


* * * * * * * * * * * * * * * * * * * * * * * * *

Información Socios

Ofertas de Trabajo
Ofertas de Trabajo SOCIOS SAMFYC

¡Actualiza tus datos!
Actualiza tus datos

 

Buscador de Contenidos

Sociedades Federadas

Medicina Familiar y Comunitaria

Sociedades Científicas de Medicina Familiar y Comunitaria

Enlaces de Interés

Consulte Nuestros Enlaces.
Enlaces de Interés

Acceso Socios



Buscador de publicaciones externas y alertas bibliográficas

Agosto 2013 PDF Imprimir E-mail
Jueves, 05 de Septiembre de 2013 00:00

Volver

SELECCIÓN DE REFERENCIAS BIBLIOGRÁFICAS DE LO PUBLICADO EN RELACIÓN CON ATENCIÓN PRIMARIA

Selección realizada por Antonio Manteca González

 

ACADEMIC MEDICINE

 

Norman G, Monteiro S, Sherbino J. Is clinical cognition binary or continuous? Acad Med. 2013; 88:1058-1060 [AO,I]

23899852             R/C

EL CONOCIMIENTO CLÍNICO ¿ES CONTINUO O DISCRETO?

 

Custers EJ. Medical education and cognitive continuum theory: an alternative perspective on medical problem solving and clinical reasoning. Acad Med. 2013; 88:1074-1010 [R,I]

23807108             R/C

LA FORMACIÓN MÉDICA Y LA TEORÍA DEL CONOCIMIENTO CLÍNICO CONTINUO: PERSPECTIVA ALTERNATIVA SOBRE LA RESOLUCIÓN DE PROBLEMAS MÉDICOS Y EL RAZONAMIENTO CLÍNICO

 

ANNALS OF INTERNAL MEDICINE

 

Taksler GB, Keshner M, Fagerlin A, Hajizadeh N, Braithwaite RS. Personalized estimates of benefit from preventive care guidelines: a proof of concept. Ann Intern Med. 2013; 159:161-168 [T,I]

23922061             R/C

ESTIMACIÓN PERSONALIZADA DEL BENEFICIO DE LAS GUÍAS DE CUIDADOS PREVENTIVOS: PRUEBA DE VIABILIDAD

 

Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013; 159:185-194 [M,III]

23922064             R/C

MONITORIZACIÓN MEDIANTE AUTOMEDICIÓN DE LA PRESIÓN ARTERIAL EN EL MANEJO DE LA HIPERTENSIÓN: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

Owens DK, Goldhaber-Fiebert JD. Prioritizing guideline-recommended interventions. Ann Intern Med. 2013; 159:223-224 [AO,I]

23922066

PRIORIZAR LAS INTERVENCIONES RECOMENDADAS POR LAS GUÍAS

 

Santa J, Lipman MM. Knowledge and ignorance in the care of chronic disease. Ann Intern Med. 2013; 159:225-226 [AO,I]

23922067

CONOCIMIENTO E IGNORANCIA EN LA ATENCIÓN A LA ENFERMEDAD CRÓNICA

 

Frances A. The new crisis in confidence in psychiatric diagnosis. Ann Intern Med. 2013 [Epub ahead of print] [AO,I]

23685989

NUEVA CRISIS DE CONFIANZA EN EL DIAGNÓSTICO PSIQUIÁTRICO

 

Moyer VA. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013 [Epub ahead of print] [M,II]

23698791             R/C

CRIBAJE E INTERVENCIONES DE CONSEJO CONDUCTUAL EN ATENCIÓN PRIMARIA PARA REDUCIR EL MAL USO DEL ALCOHOL: DECLARACIÓN DE RECOMENDACIÓN DEL US PREVENTIVE SERVICES TASK FORCE

 

BRITISH JOURNAL OF PSYCHIATRY

 

Faraone SV. Attention-deficit hyperactivity disorder and the shifting sands of psychiatric nosology. Br J Psychiatry. 2013; 203:81-83 [AO,I]

23908337             R/C

EL TRASTORNO DE HIPERACTIVIDAD Y DÉFICIT DE ATENCIÓN Y LAS ARENAS MOVEDIZAS DE LA NOSOLOGÍA PSIQUIÁTRICA

 

Meijer A, Conradi HJ, Bos EH, Anselmino M, Carney RM, Denollet J, et al. Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis. Br J Psychiatry. 2013; 203:90-102 [M,I]

23908341             R/C

ASOCIACIÓN PRONÓSTICA MODIFICADA DE LA DEPRESIÓN TRAS INFARTO DE MIOCARDIO CON MORTALIDAD Y ACONTECIMIENTOS CARDIOVASCULARES: METAANÁLISIS DE DATOS INDIVIDUALES DE PACIENTES

 

Larsson H, Rydén E, Boman M, Långström N, Lichtenstein P, Landén M. Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder. Br J Psychiatry. 2013; 203:103-106 [T,I]

23703314             R/C

RIESGO DE TRASTORNO BIPOLAR Y ESQUIZOFRENIA EN FAMILIARES DE PERSONAS CON TRASTORNO DE HIPERACTIVIDAD Y DÉFICIT DE ATENCIÓN

 

Hamshere ML, Stergiakouli E, Langley K, Martin J, Holmans P, Kent L, et al. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. Br J Psychiatry. 2013; 203:107-111 [T,I]

23703318             R/C

CONTRIBUCIÓN POLIGÉNICA COMPARTIDA ENTRE TRASTORNO DE HIPERACTIVIDAD Y DÉFICIT DE ATENCIÓN INFANTIL Y ESQUIZOFRENIA DEL ADULTO

 

Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, et al. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry. 2013; 203:112-119 [S,I]

23846996             R/C

TRATAMIENTO ESTIMULANTE PARA EL TRASTORNO DE HIPERACTIVIDAD Y DÉFICIT DE ATENCIÓN Y RIESGO DE DESARROLLAR TRASTORNO DE ABUSO DE SUSTANCIAS

 

BRITISH MEDICAL JOURNAL

 

Bartlett EC, Levison WB, Munday PE. Pelvic inflammatory disease. BMJ. 2013; 346:f3189 [R,I]

23704128

ENFERMEDAD PÉLVICA INFLAMATORIA

 

Drake T, Rustom J, Davies M. Phimosis in childhood. BMJ. 2013; 346:f3678 [R,I]

23788454

FIMOSIS E INFANCIA

 

Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ. 2013; 347:f4533 [M,II]

23900314             R/C

HIPOGLUCEMIA GRAVE Y ENFERMEDAD CARDIOVASCULAR: REVISIÓN SISTEMÁTICA Y METAANÁLISIS CON ANÁLISIS DE SESGOS

 

Reynolds RM, Allan KM, Raja EA, Bhattacharya S, McNeill G, Hannaford PC, et al. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years. BMJ. 2013; 347:f4539 [S,II]

23943697             R/C

OBESIDAD MATERNA DURANTE EL EMBARAZO Y MORTALIDAD PREMATURA POR ACONTECIMIENTO CARDIOVASCULAR EN LA DESCENDENCIA ADULTA: SEGUIMIENTO DE 1.323.275 PERSONAS-AÑO

 

Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013; 347:f4587 [M,II]

23926315             R/C

TASAS DE ERRADICACIÓN MUNDIAL DE LA INFECCIÓN POR HELICOBACTER PYLORI: REVISIÓN SISTEMÁTICA Y METAANÁLISIS DE LA TERAPIA SECUENCIAL

 

Rudge JW, Coker R. Human to human transmission of H7N9. BMJ. 2013; 347:f4730 [AO,I]

23920349

TRANSMISIÓN DEL H7N9 DE HUMANO A HUMANO

 

Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, Tang FY, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ. 2013; 347:f4752 [T,II]

23920350             R/C

PROBABLE TRASMISIÓN DE PERSONA A PERSONA DEL NUEVO VIRUS DE LA GRIPE A AVIAR (H7N9) EN CHINA ORIENTAL EN 2013: INVESTIGACIÓN EPIDEMIOLÓGICA

 

Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013; 347:f4822 [M,II]

23950195             R/C

SEGURIDAD Y EFICACIA DEL TRATAMIENTO CON HIERRO INTRAVENOSO PARA REDUCIR LOS REQUERIMIENTOS DE TRANSFUSIÓN DE SANGRE ALOGÉNICA: REVISIÓN SISTEMÁTICA Y METAANÁLISIS DE ENSAYOS CLÍNICOS ALEATORIZADOS

 

Warren JD, Rohrer JD, Rossor MN. Frontotemporal dementia. BMJ. 2013; 347:f4827 [R,I]

23920254

DEMENCIA FRONTOTEMPORAL

 

Palmsten K, Hernández-Díaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED, et al. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ. 2013; 347:f4877 [S,I]

23965506             R/C

USO DE ANTIDEPRESIVOS CERCA DEL PARTO Y RIESGO DE HEMORRAGIA POSTPARTO:_ ESTUDIO DE COHORTES DE MUJERES DE BAJOS INGRESOS EN LOS EE UU

 

Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, Bower P, et al. Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ. 2013; 347:f4913 [EC,II]

23959152             R/C

EFECTIVIDAD CLÍNICA DE LA ATENCIÓN COORDINADA DE LA DEPRESIÓN EN LA ATENCIÓN PRIMARIA EN EL RU: ENSAYO CONTROLADO ALEATORIZADO POR GRUPOS

 

Factor-Litvak P. Maternal obesity and heart disease in the offspring. BMJ. 2013; 347:f4960 [AO,I]

23943698

OBESIDAD MATERNA Y ENFERMEDAD CARDIACA EN LA DESCENDENCIA

 

Binder A, Ellis S. When to order an antinuclear antibody test. BMJ. 2013; 347:f5060 [R,I]

23965507

CUÁNDO SOLICITAR UNA ANÁLISIS DE ANTICUERPOS ANTINUCLEARES

 

Heerdink ER. Antidepressants and postpartum haemorrhage. BMJ. 2013; 347:f5194 [AO,I]

23965511

ANTIDEPRESIVOS Y HEMORRAGIA POSTPARTO

 

DIABETES CARE

 

Moreno-Castilla C, Hernandez M, Bergua M, Alvarez MC, Arce MA, Rodriguez K, et al. Low-carbohydrate diet for the treatment of gestational diabetes mellitus: a randomized controlled trial. Diabetes Care. 2013; 36:2233-2238 [EC,I]

23564917             R/C

DIETA BAJA EN CARBOHIDRATOS EN EL TRATAMIENTO DE LA DIABETES MELLITUS GESTACIONAL: ENSAYO CONTROLADO ALEATORIZADO

 

Nathan DM, Buse JB, Kahn SE, Krause-Steinrauf H, Larkin ME, Staten M, et al; GRADE Study Research Group. Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). Diabetes Care. 2013; 36:2254-2261 [EC,II]

23690531             R/C

LÓGICA Y DISEÑO DE LOS ABORDAJES PARA LA REDUCCIÓN DE LA GLUCEMIA EN LA DIABETES: ESTUDIO DE EFECTIVIDAD COMPARADA (GRADE)

 

Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013; 36:2271-2279 [T,II]

23418368             R/C

PREVALENCIA DE CONSECUCIÓN DE OBJETIVOS DE HBA1C, PRESIÓN ARTERIAL Y LDL ENTRE PERSONAS CON DIABETES

 

Bullard KM, Saydah SH, Imperatore G, Cowie CC, Gregg EW, Geiss LS, et al. Secular changes in U.S. prediabetes prevalence defined by hemoglobin A1C and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care. 2013; 36:2286-2293 [T,II]

23603918             R/C

CAMBIOS SECULARES EN LA PREVALENCIA DE DIABETES EN EE UU DEFINIDA POR LA HBA1C Y LA GLUCOSA PLASMÁTICA EN AYUNAS: ENCUESTAS DE  EXÁMENES NACIONALES DE NUTRICIÓN Y SALUD, 1999-2010

 

Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care. 2013; 36:2294-2300 [T,I]

23637352             R/C

OBESIDAD METABÓLICAMENTE SANA Y RIESGO DE MORTALIDAD:¿IMPORTA LA DEFINICIÓN DE SALUD METABÓLICA?

 

Taylor KS, Heneghan CJ, Farmer AJ, Fuller AM, Adler AI, Aronson JK, et al. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care. 2013; 36:2366-2371 [S,II]

23435157             R/C

MORTALIDAD CARDIOVASCULAR Y POR CUALQUIER CAUSA EN PERSONAS DE EDAD MEDIANA CON DIABETES TIPO 2 COMPARADAS CON PERSONAS SIN DIABETES EN UNA GRAN BASE DE DATOS DE ATENCIÓN PRIMARIA EN R.U.

 

Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, et al; North West Adelaide Health Study Team. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013; 36:2388-2394 [S,I]

23491523             R/C

RESULTADOS DE ENFERMEDAD CARDIOVASCULAR Y DIABETES EN EL FENOTIPO OBESO METABÓLICAMENTE SANO: ESTUDIO DE COHORTE

 

Hill JO, Galloway JM, Goley A, Marrero DG, Minners R, Montgomery B, et al. Scientific statement: socioecological determinants of prediabetes and type 2 diabetes. Diabetes Care. 2013; 36:2430-2439 [M,II]

23788649

DECLARACIÓN CIENTÍFICA: DETERMINANTES SOCIOECOLÓGICOS DE LA PREDIABETES Y DE LA DIABETES TIPO 2

 

DRUGS

 

Hom C, Vaezi MF. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment. Drugs. 2013; 73:1281-1295 [R,I]

23881666             R/C

MANIFESTACIONES EXTRAESOFÁGICAS DE LA ENFERMEDAD POR REFLUJO GASTROESOFÁGICO: DIAGNÓSTICO Y TRATAMIENTO

 

Rauck RL. Treatment of opioid-induced constipation: focus on the peripheral µ-opioid receptor antagonist methylnaltrexone. Drugs. 2013; 73:1297-1306 [R,I]

23881667             R/C

TRATAMIENTO DEL ESTREÑIMIENTO INDUCIDO POR OPIOIDES: ENFOQUE SOBRE EL ANTAGONISTA DEL RECEPTOR PERIFÉRICO µ-OPIOIDE METILNALTREXONA

 

Yang LP. Sumatriptan/Naproxen sodium: a review of its use in adult patients with migraine. Drugs. 2013; 73:1339-1355 [R,I]

23912627             R/C

SUMATRIPTÁN CON NAPROXENO SÓDICO: REVISIÓN DE SU USO EN PACIENTES ADULTOS CON MIGRAÑA

 

FAMILY PRACTICE

 

Agarwal G. Personal health records--an overview of the changing face of family practice. Fam Pract. 2013; 30:363-364 [AO,I]

23887635

REGISTROS DE SALUD PERSONALES: PANORÁMICA DE LA CARA CAMBIANTE DE LA MEDICINA DE FAMILIA

 

Sanders AR, van Weeghel I, Vogelaar M, Verheul W, Pieters RH, de Wit NJ, et al. Effects of improved patient participation in primary care on health-related outcomes: a systematic review. Fam Pract. 2013; 30:365-378 [M,II]

23629738             R/C

EFECTOS DE LA MEJORA DE LA PARTICIPACIÓN DEL PACIENTE EN ATENCIÓN PRIMARIA SOBRE LOS RESULTADOS RELACIONADOS CON LA SALUD: REVISIÓN SISTEMÁTICA

 

Longmier E, Barrett B, Brown R. Can patients or clinicians predict the severity or duration of an acute upper respiratory infection? Fam Pract. 2013; 30:379-385 [T,I]

23515376             R/C

¿PUEDEN PREDECIR LOS PACIENTES O LOS CLÍNICOS LA GRAVEDAD O LA DURACIÓN DE UNO INFECCIÓN AGUDA DE LAS VÍAS ALTAS RESPIRATORIAS?

 

Irving G, Holden J. The time-efficiency principle: time as the key diagnostic strategy in primary care. Fam Pract. 2013; 30:386-389 [AO,II]

23535204             R/C

EL PRINCIPIO DE LA EFICIENCIA DEL TIEMPO: EL TIEMPO COMO ESTRATEGIA DIAGNÓSTICA CLAVE EN ATENCIÓN PRIMARIA

 

Ovaisi S, Oakeshott P, Kerry S, Crabtree AE, Kyei G, Kerry SM. Home blood pressure monitoring in hypertensive stroke patients: a prospective cohort study following a randomized controlled trial. Fam Pract. 2013; 30:398-403 [S,I]

23629739             R/C

MONITORIZACIÓN DE LA PRESIÓN ARTERIAL EN LOS PACIENTES HIPERTENSOS CON ICTUS: ESTUDIO PROSPECTIVO DE COHORTES TRAS UN ENSAYO ALEATORIZADO CONTROLADO

 

Willems IA, Gorgels WJ, Oude Voshaar RC, Mulder J, Lucassen PL. Tolerance to benzodiazepines among long-term users in primary care. Fam Pract. 2013; 30:404-410 [T,I]

23515374             R/C

TOLERANCIA A LAS BENZODIACEPINAS ENTRE LOS USUARIOS DE ELLAS A LARGO PLAZO EN ATENCIÓN PRIMARIA

 

Stewart M, Fortin M, Britt HC, Harrison CM, Maddocks HL. Comparisons of multi-morbidity in family practice--issues and biases. Fam Pract. 2013; 30:473-480 [T,I]

23666805             R/C

COMPARACIONES DE PLURIMORBILIDAD EN MEDICINA DE FAMILIA-- PROBLEMAS Y SESGOS

 

GACETA SANITARIA

 

Rodríguez A, Urdaneta E, de la Fuente M, Galindo E, Yanguas JJ, Rodríguez V. Análisis del sesgo de selección en el piloto de un estudio longitudinal sobre envejecimiento en España. Gac Sanit. 2013; 27:425-432 [T,I]

23291032             R/C

ANÁLISIS DEL SESGO DE SELECCIÓN EN EL PILOTO DE UN ESTUDIO LONGITUDINAL SOBRE ENVEJECIMIENTO EN ESPAÑA

 

Olabarria M, Pérez K, Santamariña-Rubio E, Aragay JM, Capdet M, Peiró R, et al. Trabajo, familia y movilidad diaria: una nueva aproximación al problema a través de una encuesta de movilidad.  Gac Sanit. 2013; 27:433-439 [T,I]

23122515             R/C

TRABAJO, FAMILIA Y MOVILIDAD DIARIA: UNA NUEVA APROXIMACIÓN AL PROBLEMA A TRAVÉS DE UNA ENCUESTA DE MOVILIDAD

 

Sonego M, Gandarillas A, Zorrilla B, Lasheras L, Pires M, Anes A, et al. Violencia de pareja no percibida y salud de las mujeres. Gac Sanit. 2013; 27:440-446 [T,I]

23337515             R/C

VIOLENCIA DE PAREJA NO PERCIBIDA Y SALUD DE LAS MUJERES

 

Zambrana-García JL, Rivas-Ruiz F; en nombre del Grupo para el Análisis de la Calidad del Informe de Alta Hospitalaria en los Hospitales de Alta Resolución de Andalucía. Calidad de los informes de alta hospitalaria respecto a la legislación vigente y las recomendaciones consensuadas por expertos. Gac Sanit. 2013; 27:450-453 [T,I]

23207430             R/C

CALIDAD DE LOS INFORMES DE ALTA HOSPITALARIA RESPECTO A LA LEGISLACIÓN VIGENTE Y LAS RECOMENDACIONES CONSENSUADAS POR EXPERTOS

 

García F. Cooperación para la innovación europea en el envejecimiento activo y saludable: de la política a la acción. Gac Sanit. 2013; 27:459-462 [AO,I]

23140981             R/C

COOPERACIÓN PARA LA INNOVACIÓN EUROPEA EN EL ENVEJECIMIENTO ACTIVO Y SALUDABLE: DE LA POLÍTICA A LA ACCIÓN

 

GUT

 

Tilg H, Gasbarrini A. Prebiotics for obesity: a small light on the horizon? Gut. 2013; 62:1096-1097 [AO,I]

23315500

PREBIÓTICOS EN LA OBESIDAD: ¿UNA LUCECITA EN EL HORIZONTE?

 

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

 

Tol WA, Barbui C, van Ommeren M. Management of acute stress, PTSD, and bereavement: WHO recommendations. JAMA. 2013; 310:477-478 [AO,II]

23925613

MANEJO DEL ESTRÉS AGUDO, TRASTORNO DE ESTRÉS POSTRAUMÁTICO Y DUELO: RECOMENDACIONES DE LA OMS

 

Feder G, Wathen CN, MacMillan HL. An evidence-based response to intimate partner violence: WHO guidelines. JAMA. 2013; 310:479-480 [M,II]

23925614

RESPUESTA BASADA EN LA EVIDENCIA A LA VIOLENCIA DE PAREJA: PAUTAS DE LA OMS

 

North CS, Pfefferbaum B. Mental health response to community disasters: a systematic review. JAMA. 2013; 310:507-518 [M,II]

23925621             R/C

RESPUESTA DE LA SALUD MENTAL A LAS CATÁSTROFES COMUNITARIAS: REVISIÓN SISTEMÁTICA

 

MEDICINA CLINICA

 

Ruiz de Viñaspre R, Rubio E, Tomás C. Incontinencia urinaria a los 6 meses del parto. Med Clin (Barc). 2013; 141:145-151 [S,I]

22818183             R/C

INCONTINENCIA URINARIA A LOS 6 MESES DEL PARTO

 

López A, Costa J. Guía de consenso sobre los contenidos de los protocolos de ensayos clínicos. Med Clin (Barc). 2013; 141:161-162 [AO,I]

23540380

GUÍA DE CONSENSO SOBRE LOS CONTENIDOS DE LOS PROTOCOLOS DE ENSAYOS CLÍNICOS

 

Camafort-Babkowski M. Impacto del tratamiento antidiabético con fármacos agonistas del receptor de péptido de tipo 1 similar al glucagón en el riesgo cardiovascular de pacientes con diabetes mellitus tipo 2. Med Clin (Barc). 2013; 141:167-174 [R,I]

23332622             R/C

IMPACTO DEL TRATAMIENTO ANTIDIABÉTICO CON FÁRMACOS AGONISTAS DEL RECEPTOR DE PÉPTIDO DE TIPO 1 SIMILAR AL GLUCAGÓN EN EL RIESGO CARDIOVASCULAR DE PACIENTES CON DIABETES MELLITUS TIPO 2

 

Basterra V. Riesgo de problemas de salud mental en España y distribución por regiones. Med Clin (Barc). 2013; 141:181-182 [AO,I]

23510609

RIESGO DE PROBLEMAS DE SALUD MENTAL EN ESPAÑA Y DISTRIBUCIÓN POR REGIONES

 

REVISTA ESPAÑOLA DE CARDIOLOGIA

 

López-de-Sá E, López-Sendón J. Supervivientes a parada cardiaca antes de llegar al hospital. Más allá de la reanimación cardiopulmonar. Rev Esp Cardiol. 2013; 66:606-608 [AO,I]

23809868

SUPERVIVIENTES A PARADA CARDIACA ANTES DE LLEGAR AL HOSPITAL. MÁS ALLÁ DE LA REANIMACIÓN CARDIOPULMONAR

 

Sayago-Silva I, García-López F, Segovia-Cubero J. Epidemiología de la insuficiencia cardiaca en España en los últimos 20 años. Rev Esp Cardiol. 2013; 66:649-656 [R,I]

23830060             R/C

EPIDEMIOLOGÍA DE LA INSUFICIENCIA CARDIACA EN ESPAÑA EN LOS ÚLTIMOS 20 AÑOS

 

THE LANCET

 

Meningitis B. Lancet. 2013; 382:368 [AO,I]

23911364

MENINGITIS

 

Morley JE, Sinclair A. Individualising treatment for older people with diabetes. Lancet. 2013; 382:378-380 [AO,I]

23706758

INDIVIDUALIZAR EL TRATAMIENTO DE LAS PERSONAS MAYORES CON DIABETES

 

THE NEW ENGLAND JOURNAL OF MEDICINE

 

Salathé M, Freifeld CC, Mekaru SR, Tomasulo AF, Brownstein JS. Influenza A (H7N9) and the importance of digital epidemiology. N Engl J Med. 2013; 369:401-404 [AO,I]

23822655

LA GRIPE A (H7N9) Y LA IMPORTANCIA DE LA EPIDEMIOLOGÍA DIGITAL

 

Daschle T, Domenici P, Frist W, Rivlin A. Prescription for patient-centered care and cost containment. N Engl J Med. 2013; 369:471-474 [AO,I]

23803133

PRESCRIPCIÓN EN LA ATENCIÓN CENTRADA EN EL PACIENTE Y CONTENCIÓN DE COSTES

 

Morain S, Greene MF, Mello MM. A new era in noninvasive prenatal testing. N Engl J Med. 2013; 369:499-501 [AO,I]

23862975

UNA NUEVA ERA EN LAS PRUEBAS PRENATALES NO INVASIVAS

 

Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, et al. Glucose levels and risk of dementia. N Engl J Med. 2013; 369:540-548 [S,I]

23924004             R/C

NIVELES DE GLUCOSA Y RIESGO DE DEMENCIA

 

Rando TA, Finkel T. Cardiac aging and rejuvenation--a sense of humors? N Engl J Med. 2013; 369:575-576 [AO,I]

23924010

ENVEJECIMIENTO CARDIACO Y REJUVENECIMIENTO ¿SENTIDO DEL HUMOR?

 

THORAX

 

Cossette B, Forget A, Beauchesne MF, Rey E, Lemière C, Larivée P, et al. Impact of maternal use of asthma-controller therapy on perinatal outcomes. Thorax. 2013; 68:724-730 [S,I]

23585516             R/C

IMPACTO DEL USO MATERNO DE TERAPIA PARA CONTROLAR EL ASMA SOBRE LOS RESULTADOS PERINATALES

 

 

ACADEMIC MEDICIE

 

S23899852  

A dominant theory of clinical reasoning is the so-called "dual processing theory," in which the diagnostic process may proceed through a rapid, unconscious, intuitive process (System 1) or a slow, conceptual, analytical process (System 2). Diagnostic errors are thought to arise primarily from cognitive biases originating in System 1. In this issue, Custers points out that this model is unnecessarily restrictive and that it is more likely that diagnostic tasks may proceed through a variety of mental strategies ranging from "analytical" to "intuitive."The authors of this commentary agree that the notion that System 1 and System 2 processes are somehow in competition and will necessarily lead to different conclusions is unnecessarily restrictive. On the other hand, they argue that there is substantial evidence in support of a dual processing model, and that most objections to dual processing theory can be easily accommodated by simply presuming that both processes operate in concertand that solving any task may rely to varying degrees on both processes.

S23807108  

Recently, human reasoning, problem solving, and decision making have been viewed as products of two separate systems: "System 1," the unconscious, intuitive, or nonanalytic system, and "System 2," the conscious, analytic, or reflective system. This view has penetrated the medical education literature, yet the idea of two independent dichotomous cognitive systems is not entirely without problems.This article outlines the difficulties of this "two-system view" and presents an alternative, developed by K.R. Hammond and colleagues, called cognitive continuum theory (CCT). CCT is featured by three key assumptions. First, human reasoning, problem solving, and decision making can be arranged on a cognitive continuum, with pure intuition at one end, pure analysis at the other, and a large middle ground called "quasirationality." Second, the nature and requirements of the cognitive task, as perceived by the person performing the task, determine to a large extent whether a task will be approached more intuitively or more analytically. Third, for optimal task performance, this approach needs to match the cognitive properties and requirements of the task. Finally, the author makes a case that CCT is better able than a two-system view to describe medical problem solving and clinical reasoning and that it provides clear clues for how to organize training in clinical reasoning.

 

ANNALS OF INTERNAL MEDICINE

 

S23698791  

The USPSTF recommends that clinicians screen adults aged 18 years or older for alcohol misuse and provide persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce alcohol misuse. (Grade B recommendation)The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening and behavioral counseling interventions in primary care settings to reduce alcohol misuse in adolescents. (I statement).

S23922064  

Self-measured BP monitoring with or without additional support lowers BP compared with usual care, but the BP effect beyond 12 months and long-term benefits remain uncertain. Additional support enhances the BP-lowering effect.

S23922061  

Models of personalized preventive care may illustrate how magnitude and rank order of benefit associated with preventive guidelines vary across recommendations and patients. These predictions may help clinicians to prioritize USPSTF recommendations at the patient level.

 

BRITISH JOURNAL OF PSYCHIATRY

 

S23703314 

These findings suggest that the co-occurrence of ADHD and bipolar disorder as well as ADHD and schizophrenia is due to shared genetic factors, rather than representing completely aetiologically distinct subsyndromes.

S23703318 

This increasing evidence for a small, but significant, shared genetic susceptibility between adult schizophrenia and childhood ADHD highlights the importance of research work across traditional diagnostic boundaries.

S23846996 

Stimulant treatment appears to lower the risk of developing substance use disorders and does not have an impact on the development of nicotine dependence in adolescents with ADHD.

S23908341 

The association between depression following myocardial infarction and prognosis is attenuated after adjustment for cardiac disease severity. Still, depression remains independently associated with prognosis, with a 22% increased risk of all-cause mortality and a 13% increased risk of cardiovascular events per standard deviation in depression z-score.

S23908337 

Larsson et al provide epidemiological evidence for a genetic association between attention-deficit hyperactivity disorder (ADHD) and both bipolar disorder and schizophrenia and Hamshere and colleagues confirm the latter association with genome-wide data. Although a genetic link between ADHD and bipolar disorder has been hypothesised for over a decade, the association with schizophrenia fills a notable gap in the literature. This editorial discusses the implications of these findings for clinicians, who must address psychiatric comorbidity in their treatment formulations, and researchers who are learning that the discrete categorical diagnoses of our diagnostic systems may not be up to the task of clarifying the causes and cures of psychopathology.

 

BRITISH MEDICAL JOURNAL

 

S23950195 

Intravenous iron therapy is effective in increasing haemoglobin concentration and reducing the risk of allogeneic red blood cell transfusion and could have broad applicability to a range of acute care settings. This potential benefit is counterbalanced by a potential increased risk of infection.

S23920350  

The infection of the daughter probably resulted from contact with her father (the index patient) during unprotected exposure, suggesting that in this cluster the virus was able to transmit from person to person. The transmissibility was limited and non-sustainable.

S23900314 

Our findings suggest that severe hypoglycaemia is associated with a higher risk of cardiovascular disease; they also support the notion that avoiding severe hypoglycaemia may be important to prevent cardiovascular disease in people with type 2 diabetes.

S23943697 

Maternal obesity is associated with an increased risk of premature death in adult offspring. As one in five women in the United Kingdom is obese at antenatal booking, strategies to optimise weight before pregnancy are urgently required.

S23965506 

Exposure to serotonin and non-serotonin reuptake inhibitors, including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and tricyclics, close to the time of delivery was associated with a 1.4 to 1.9-fold increased risk for postpartum hemorrhage. While potential confounding by unmeasured factors cannot be ruled out, these findings suggest that patients treated with antidepressants during late pregnancy are more likely to experience postpartum hemorrhage.

S23959152 

Collaborative care has persistent positive effects up to 12 months after initiation of the intervention and is preferred by patients over usual care.

S23926315 

Eradication rates with pre-existing and new therapies for H pylori are suboptimal. Regional monitoring of resistance rates should help to guide treatment, and new agents for treatment need to be developed.

 

DIABETES CARE

 

S23690531 

GRADE will compare the long-term effectiveness of major glycemia-lowering medications and provide guidance to clinicians about the most appropriate medications to treat T2DM. GRADE begins recruitment at 37 centers in the U.S. in 2013.

S23603918 

During 1999-2010, U.S. prediabetes prevalence increased because of increases in A1C5.7. Continuous monitoring of prediabetes is needed to identify, quantify, and characterize the population of high-risk individuals targeted for ongoing diabetes primary prevention efforts.

S23418368 

Despite significant improvement during the past decade, achieving the ABC goals remains suboptimal among adults with diabetes, particularly in some minority groups. Substantial opportunity exists to further improve diabetes control and, thus, to reduce diabetes-related morbidity and mortality.

S23435157 

Despite efforts to manage risk factors, administer effective treatments, and develop new therapies, middle-aged people with type 2 diabetes remain at significantly increased risk of death.

S23491523 

"Healthy" obesity was a transient state for one-third of subjects. Persistence of a MHO phenotype, which was associated with favorable outcomes, was related to younger age and a more peripheral fat distribution. The MHO phenotype may be sustained by promoting lower waist circumferences.

S23564917 

Treatment of women with GDM using a low-CHO diet did not reduce the number of women needing insulin and produced similar pregnancy outcomes. In GDM, CHO amount (40 vs. 55% of calories) did not influence insulin need or pregnancy outcomes.

S23637352 

For most definitions of metabolic health, both metabolically healthy and unhealthy obese patients carry an elevated risk of mortality.

 

DRUGS

 

S23912627  

A fixed-dose combination of sumatriptan/naproxen sodium (Treximet(®)) has been approved in the US for the acute treatment of migraine in adults. In two randomized trials, sumatriptan/naproxen sodium demonstrated significantly better efficacy than sumatriptan alone, naproxen sodium alone, or placebo as late-intervention therapy for a single migraine episode in adults, as assessed by co-primary efficacy endpoints evaluating pain and other migraine-related symptoms, as well as health-related quality of life (HR-QOL) endpoints. In four other randomized trials, the drug combination was also effective as early intervention in adults with migraine (including those with menstrual migraine and dysmenorrhoea, or those with poor response or intolerance to triptan therapy) according to various pain-related primary efficacy and HR-QOL endpoints. Data from longer-term, non-randomized studies support these findings, and the drug combination appears to be beneficial in patients with migraine and cutaneous allodynia. In clinical trials, sumatriptan/naproxen sodium was generally well tolerated, with an overall tolerability profile similar to that of sumatriptan. The most common adverse events were in line with those expected for sumatriptan and naproxen sodium. Current data indicate that sumatriptan/naproxen sodium is a useful option in the treatment of adult migraine.

S23881667  

Most prescribed opioids exert their analgesic effects via activation of central µ-opioid receptors. However, µ-opioid receptors are also located in the gastrointestinal (GI) tract, and activation of these receptors by opioids can lead to GI-related adverse effects, in particular opioid-induced constipation (OIC). OIC has been associated with increased use of healthcare resources, increased healthcare costs, and decreased quality of life for patients. Nonpharmacologic (e.g., increased fiber uptake) and pharmacologic agents (e.g., laxatives) may be considered for the treatment and prevention of OIC. However, many interventions, such as laxatives alone, are generally insufficient to reverse OIC because they do not target the underlying cause of OIC, opioid activation of µ-opioid receptors in the GI tract. Therefore, there has been keen interest in antagonism of the µ-opioid receptor in the periphery to inhibit the effects of opioids in the GI tract. In this review, currently available pharmacologic therapies for the treatment and prevention of OIC are summarized briefly, with a primary focus on the administration of the peripheral µ-opioid receptor antagonist methylnaltrexone bromide in patients with OIC and advanced illness who are receiving palliative care. Also, clinical trial data of methylnaltrexone treatment in patients with OIC and other pain conditions (i.e., chronic noncancer pain and pain after orthopedic surgery) are reviewed. Data support that methylnaltrexone is efficacious for the treatment of OIC and has a favorable tolerability profile.

S23881666  

Gastroesophageal reflux disease (GERD) is a common disease that is often diagnosed based on typical symptoms of heartburn and regurgitation. In addition to these more classic manifestations, GERD is increasingly associated with extra-esophageal symptoms, including chronic cough, asthma, laryngitis, and dental erosions. Due to the poor sensitivity of endoscopy and pH monitoring, and the poor specificity of laryngoscopy, empiric therapy with proton pump inhibitors (PPIs) is now considered the initial diagnostic step in patients suspected of having GERD-related symptoms. For those who improve with PPIs, GERD is the presumed etiology, but for those who remain unresponsive to such therapy, further diagnostic testing with impedance/pH monitoring may be necessary in order to exclude refractory acid or weakly acid reflux. In those with normal test results despite PPI therapy and continued symptoms, causes other than GERD may be pursued. Recent data suggest that in patients with extra-esophageal symptoms, objective findings of moderate-sized hiatal hernia and moderate reflux on pH testing may predict response to acid suppressive therapy. PPI-unresponsive patients usually have causes other than GERD for their extra-esophageal symptoms and continued PPI therapy in this group is not recommended.

 

FAMILY PRACTICE

 

S23629738 

Little research has been performed on health outcomes of interventions aiming to increase patient participation in general practice visits among patients suffering from symptom-based complaints. The results still are non-conclusive. The quality of the trials has been weak, possibly due to the complexity of the concept. This weak quality may explain the lack of conclusive results. Proposals for future research designs are offered.

S23629739 

Around half of hypertensive stroke patients offered a blood pressure monitor but no support continued to use it after 6 and 18 months. Monitoring in the first month was common in those who were not anxious or disabled.

S23535204 

The test and retest opportunity afforded by reviewing a patient over time substantially increases the total gain in certainty when making a diagnosis in low-prevalence settings (the time-efficiency principle). This approach safely and efficiently reduces the number of patients who need to be formally tested in order to make a correct diagnosis for a person. Time, in terms of observed disease trajectory, provides a vital mechanism for achieving this task. It remains the best strategy for delivering near-optimal diagnoses in low-prevalence settings and should be used to its full advantage.

S23515374 

There is no increase in prescribed dose among long-term users, as might be expected due to the development of tolerance to the effects of benzodiazepines.

S23515376 

Clinicians should not use their predictive assessments or their patients' predictions when advising patients on the expected course of a URI. This study also suggests that the WURSS instrument could give some predictive information, but whether this is clinically useful is uncertain.

S23666805 

Understanding the differences among the methods used to produce prevalence data on multi-morbidity in primary care can help explain the varying results. Standardization of methods would allow for more valid inter-study comparisons.

 

GACETA SANITARIA

 

S23122515  

This study confirms the different mobility patterns in men and women, related to their distinct positions in the occupational, family and domestic spheres. Gender inequalities in mobility within the working population are largely determined by the greater responsibility of women in the domestic and family sphere. This finding should be taken into account in the design of future transport policies.

S23337515  

uIPV is 2.6 times more frequent than pIPV and is associated with at least as many health problems as pIPV.

S23140981  

El envejecimiento es un reto común en la Unión Europea, que incrementará la necesidad de ayuda a domicilio y el consumo de servicios sanitarios, presionando con ello nuestro sistema de bienestar. Una visión más colaborativa, integrada y centrada en el paciente-ciudadano parece ofrecer una respuesta más sostenible y eficiente a los modelos actuales. Abordajes innovadores para la patología crónica y la prevención del deterioro funcional permitirán vivir más y con mejor calidad de vida. Para hacer realidad el potencial beneficio de estas intervenciones, la Comisión Europea, en su política de «Unión para la innovación», ha lanzado la iniciativa «Cooperación para la innovación europea en el envejecimiento activo y saludable». La promoción de la participación y la colaboración de todos los actores en la cadena de cuidados son esenciales. Este artículo describe el fundamento teórico, el desarrollo de la iniciativa, sus expectativas y las primeras acciones.

S23291032 

Un muestreo probabilístico en puntos de muestreo elegidos por conveniencia permitiría dedicar más recursos a aumentar las tasas de respuesta en los colectivos menos participativos. Se propone la concentración de las preguntas en un solo cuestionario más breve previo a la extracción de sangre.

S23207430 

Los informes de alta hospitalaria ofrecen un excelente grado de cumplimentación de los datos exigidos por la normativa vigente, pero deben mejorar en su calidad intrínseca.

 

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

 

S23925621  

In postdisaster settings, a systematic framework of case identification, triage, and mental health interventions should be integrated into emergency medicine and trauma care responses.

 

MEDICINA CLINICA

 

S23332622  

Los fármacos antidiabéticos tienen, además de su conocido efecto hipoglucemiante, diferentes efectos sobre el resto de los factores de riesgo cardiovascular asociados a diabetes mellitus. Recientemente se han incorporado al arsenal terapéutico de la diabetes mellitus de tipo 2 los agonistas del receptor del glucagon-like peptide-1 (AR-GLP-1, «péptido tipo 1 similar al glucagón»). El objetivo de este trabajo es resumir la evidencia disponible sobre el efecto de los AR-GLP-1 en diferentes factores de riesgo cardiovascular, mediado tanto por el efecto hipoglucemiante de los AR-GLP-1 como por su efecto sobre los demás factores de riesgo cardiovascular (control del peso, presión arterial, perfil lipídico y otros marcadores de riesgo cardiovascular). Además, se presenta la incipiente evidencia con respecto al impacto que el tratamiento con AR-GLP-1 pudiera tener en la reducción de los episodios cardiovasculares y los estudios que hay actualmente en marcha para abordar este aspecto.

S22818183  

Un 21,4% de mujeres con incontinencia urinaria causada por embarazo/parto seguirán padeciéndola pasados 6 meses del alumbramiento. Parte importante de esta persistencia se asocia a factores fácilmente modificables.

 

REVISTA ESPAÑOLA DE CARDIOLOGIA

 

S23830060 

La insuficiencia cardiaca en un problema sanitario de primer orden en nuestro país, aunque no disponemos de cifras que permitan dimensionar su impacto con exactitud por falta de estudios con diseño apropiado. Frente a una prevalencia de insuficiencia cardiaca del 2% en otros países europeos y en Estados Unidos, los estudios en España arrojan cifras del 5%, probablemente a causa de sus limitaciones metodológicas. La insuficiencia cardiaca consume enormes recursos sanitarios: es la primera causa de hospitalización de mayores de 65 años y representa el 3% de todos los ingresos hospitalarios y el 2,5% del coste de la asistencia sanitaria. Hay dos patrones de insuficiencia cardiaca, uno con función sistólica preservada, más asociado a la hipertensión, y otro con función deprimida, más relacionado con la cardiopatía isquémica. En 2010, la insuficiencia cardiaca constituyó el 3% del total de defunciones de varones y el 10% de las de mujeres. La tasa de mortalidad por insuficiencia cardiaca ha ido reduciéndose en los últimos años. Los cambios temporales en la codificación diagnóstica podrían explicar parte del aumento en los ingresos hospitalarios y del descenso en la mortalidad por insuficiencia cardiaca, aunque hay indicios de que la adherencia a las guías de práctica clínica puede haber reducido su mortalidad.

 

THE NEW ENGLAND JOURNAL OF MEDICINE

 

S23924004  

Our results suggest that higher glucose levels may be a risk factor for dementia, even among persons without diabetes. (Funded by the National Institutes of Health.)

 

THORAX

 

S23585516

Despite the possibility of residual confounding due to uncontrolled or more severe asthma or smoking status, the use of LABA and low to moderate doses of ICSs were not associated with increased prevalence of perinatal outcomes. Additional research on higher ICSs doses is required to better evaluate their safety during pregnancy.

 

 

 

                      

XXVIII Congreso de Comunicación y Salud

 

 

semFYC - JRT 2017

 

Cáceres, 10 y 11 de Noviembre 2017


____________________________

 Para pacientes
@pontealdiaAP
 @pontealdiaURG
55 e.SAMFyC

 


 

semFYC
 

 

Estadisticas

Ver contenido por hits : 1098943



La SAMFyC:
 C/ Arriola, 4, bajo D, CP.18001 - Granada. Email: samfyc@samfyc.es; Teléfono: 958 804 201 - Fax: 958 804 202. Horario de invierno: lunes a jueves de 9:00 a 17:30 horas; viernes de 9:00 a 14:30 horas. Horario de verano: lunes a viernes de 8:00 a 15:00h. Todos los derechos reservados. Aviso Legal. 


¡CSS Válido!

Diseño web